Is MRD Negativity the New Benchmark in ALL Treatment Strategies?
The HemOnc Pulse
Introduction
Exploring the complexities of treating acute lymphoblastic leukemia in adults, including discussions on MRD negativity, targeted therapies, and immunotherapy to improve cure rates. Contrasting outcomes in pediatric and adult patients are highlighted, with a focus on novel approaches to enhance survival in adult ALL cases.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
